@article{UBHD-68666413, author={B{\"o}ck, Stefan and Jung, A. and Laubender, R. P. and Neumann, J. and Egg, R. and Goritschan, C. and Vehling-Kaiser, U. and Winkelmann, C. and Fischer von Weikersthal, L. and Clemens, M. R. and Gauler, T. C. and M{\"a}rten, Angela and Klein, S. and Kojouharoff, G. and Barner, M. and Geissler, M. and Greten, T. F. and Mansmann, U. and Kirchner, T. and Heinemann, V.}, title={EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer}, subtitle={translational results from the randomised, crossover phase 3 trial AIO-PK0104}, year={2013}, pages={469-476}, language={eng}, issn={1532-1827}, volume={108}, number={2}, note={published online 20 November 2012 ; Gesehen am 27.11.2020}, journal={British journal of cancer}, doi={10.1038/bjc.2012.495}, } @article{UBHD-69010582, author={B{\"o}ck, Stefan and Vehling-Kaiser, Ursula and Waldschmidt, Dirk and Kettner, Erika and M{\"a}rten, Angela and Winkelmann, Cornelia and Klein, Stefan and Kojouharoff, Georgi and Gauler, Thomas and Fischer von Weikersthal, Ludwig and Clemens, Michael R. and Geißler, Michael and Greten, Tim F. and Hegewisch-Becker, Susanna and Neugebauer, Sascha and Heinemann, Volker}, title={Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer}, subtitle={an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the "Arbeitsgemeinschaft Internistische Onkologie"}, year={2010}, pages={94-100}, language={eng}, issn={1473-5741}, volume={21}, number={1}, note={Gesehen am 26.01.2023}, journal={Anti-cancer drugs}, doi={10.1097/CAD.0b013e32833123ed}, } @article{UBHD-67657189, author={Fensterer, Heiko and M{\"a}rten, Angela and Ebert, Matthias and Hofheinz, Ralf-Dieter}, title={Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)}, year={2013}, pages={2576-2581}, language={eng}, issn={1569-8041}, volume={24}, number={10}, note={Gesehen am: 07.08.2014}, journal={Annals of oncology}, doi={10.1093/annonc/mdt270}, } @article{UBHD-68713964, author={Heinemann, Volker and Vehling-Kaiser, Ursula and Waldschmidt, Dirk and Kettner, Erika and M{\"a}rten, Angela and Winkelmann, Cornelia and Klein, Stefan and Kojouharoff, Georgi and Gauler, Thomas C. and Weikersthal, Ludwig Fischer von and Clemens, Michael R. and Geißler, Michael and Greten, Tim F. and Hegewisch-Becker, Susanna and Rubanov, Oleg and Baake, Gerold and H{\"o}hler, Thomas and Ko, Yon D. and Jung, Andreas and Neugebauer, Sascha and Boeck, Stefan}, title={Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer}, subtitle={final results of a randomised phase 3 trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’ (AIO-PK0104)}, year={2013}, pages={751-759}, language={eng}, issn={1468-3288}, volume={62}, number={5}, note={Gesehen am 18.03.2021 ; Published Online First 5 April 2012}, journal={Gut}, doi={10.1136/gutjnl-2012-302759}, } @article{UBHD-68295708, author={Khallouf, Hadeel and M{\"a}rten, Angela and Serba, Susanne and Teichgr{\"a}ber, Volker and B{\"u}chler, Markus W. and J{\"a}ger, Dirk and Schmidt, Jan}, title={5-fluorouracil and interferon-α immunochemotherapy enhances immunogenicity of murine pancreatic cancer through upregulation of NKG2D ligands and MHC class I}, year={2012}, pages={245-253}, language={eng}, issn={1537-4513}, volume={35}, number={3}, note={Gesehen am 15.08.2018}, journal={Journal of immunotherapy}, doi={10.1097/CJI.0b013e31824b3a76}, } @article{UBHD-68874275, author={Knaebel, Hanns-Peter and M{\"a}rten, Angela and Schmidt, Jan and Hoffmann, Katrin and Seiler, Christoph and Lindel, Katja and Schmitz-Winnenthal, Friedrich Hubertus and Fritz, Stefan and Herrmann, Thomas and Goldschmidt, Hartmut and Krempien, Robert and Mansmann, Ulrich and Debus, J{\"u}rgen and Diehl, Volker and B{\"u}chler, Markus W.}, title={Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma - CapRI}, subtitle={study protocol (ISRCTN62866759)}, year={2005}, pages={1-8}, language={eng}, issn={1471-2407}, volume={5}, number={Artikel-ID 37}, note={Gesehen am 04.02.2022}, journal={BMC cancer}, doi={10.1186/1471-2407-5-37}, } @article{UBHD-68582156, author={Kruger, Stephan and Boeck, Stefan and Heinemann, Volker and Laubender, Ruediger P. and Vehling-Kaiser, Ursula and Waldschmidt, Dirk and Kettner, Erika and M{\"a}rten, Angela and Winkelmann, Cornelia and Klein, Stefan and Kojouharoff, Georgi and Gauler, Thomas C. and Weikersthal, Ludwig Fischer von and Clemens, Michael R. and Geißler, Michael and Greten, Tim F. and Hegewisch-Becker, Susanna and Modest, Dominik Paul and Stintzing, Sebastian and Haas, Michael}, title={Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer}, subtitle={a subgroup analysis from AIO-PK0104}, year={2015}, pages={993-1000}, language={eng}, issn={1651-226X}, volume={54}, number={7}, note={Gesehen am 29.05.2020}, journal={Acta oncologica}, doi={10.3109/0284186X.2015.1034877}, } @article{UBHD-69121854, author={Lilienfeld-Toal, Marie von and Frank, Susanne and Leyendecker, Christiane and Feyler, Sylvia and Jarmin, Sarah and Morgan, Ruth and Glasmacher, Axel and M{\"a}rten, Angela and Schmidt-Wolf, Ingo G. H. and Brossart, Peter and Cook, Gordon}, title={Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked}, year={2010}, pages={829-839}, language={eng}, issn={1432-0851}, volume={59}, number={6}, note={Online ver{\"o}ffentlicht am 19. Dezember 2009 ; Gesehen am 14.09.2023}, journal={Cancer immunology immunotherapy}, doi={10.1007/s00262-009-0807-3}, } @article{UBHD-68676400, author={M{\"a}rten, Angela and Schmidt, Jan and Ose, Jennifer and Harig, Sabine and Abel, Ulrich and M{\"u}nter, Marc and J{\"a}ger, Dirk and Friess, Helmut and Mayerle, Julia and Adler, Guido and Seufferlein, Thomas and Greß, Thomas and Schmid, Roland and B{\"u}chler, Markus W.}, title={A randomized multicentre phase II trial comparing adjuvant therapy in patients with Interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2}, year={2009}, pages={8 S.}, language={eng}, issn={1471-2407}, volume={9(2009) Artikel-Nummer 160}, number={8 Seiten}, journal={BMC cancer}, doi={10.1186/1471-2407-9-160}, } @article{UBHD-68751074, author={M{\"a}rten, Angela and B{\"u}chler, Markus W. and Werft, Wiebke and Wente, Moritz N. and Kirschfink, Michael and Schmidt, Jan}, title={Soluble iC3b as an early marker for pancreatic adenocarcinoma is superior to CA19.9 and radiology}, year={2010}, pages={219-224}, language={eng}, issn={1537-4513}, volume={33}, number={2}, note={Gesehen am 21.06.2021}, journal={Journal of immunotherapy}, doi={10.1097/CJI.0b013e3181bed29f}, } @article{UBHD-68635426, author={Ormanns, Steffen and Siveke, Jens T. and Heinemann, Volker and Haas, Michael and Sipos, Bence and Schlitter, Anna Melissa and Esposito, Irene and Jung, Andreas and Laubender, R{\"u}diger P. and Kruger, Stephan and Vehling-Kaiser, Ursula and Winkelmann, Cornelia and Fischer von Weikersthal, Ludwig and Clemens, Michael R. and Gauler, Thomas C. and M{\"a}rten, Angela and Geißler, Michael and Greten, Tim F. and Kirchner, Thomas and Boeck, Stefan}, title={pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer}, subtitle={a translational subgroup analysis from AIO-PK0104}, year={2014}, pages={10 S.}, language={eng}, issn={1471-2407}, volume={14}, note={Gesehen am 09.09.2020}, journal={BMC cancer}, doi={10.1186/1471-2407-14-624}, }